The fully linked HTML version of this article has now been published.
Development ePress online publication date 23 Jan 2008
doi: 10.1242/dev.011569
Research article
Specific regions within the embryonic midbrain and cerebellum require different levels of FGF signaling during development
M. Albert Basson,
Diego Echevarria,
Christina Petersen Ahn,
Anamaria Sudarov,
Alexandra L. Joyner,
Ivor J. Mason,
Salvador Martinez,
and
Gail R. Martin*
* Author for correspondence (e-mail: gail.r.martin{at}ucsf.edu)
Prospective midbrain and cerebellum formation are coordinated by FGF ligands produced by the isthmic organizer. Previous studies have suggested that midbrain and cerebellum development require different levels of FGF signaling. However, little is known about the extent to which specific regions within these two parts of the brain differ in their requirement for FGF signaling during embryogenesis. Here, we have explored the effects of inhibiting FGF signaling within the embryonic mouse midbrain (mesencephalon) and cerebellum (rhombomere 1) by misexpressing sprouty2 (Spry2) from an early stage. We show that such Spry2 misexpression moderately reduces FGF signaling, and that this reduction causes cell death in the anterior mesencephalon, the region furthest from the source of FGF ligands. Interestingly, the remaining mesencephalon cells develop into anterior midbrain, indicating that a low level of FGF signaling is sufficient to promote only anterior midbrain development. Spry2 misexpression also affects development of the vermis, the part of the cerebellum that spans the midline. We found that, whereas misexpression of Spry2 alone caused loss of the anterior vermis, reducing FGF signaling further, by decreasing Fgf8 gene dose, resulted in loss of the entire vermis. Our data suggest that cell death is not responsible for vermis loss, but rather that it fails to develop because reducing FGF signaling perturbs the balance between vermis and roof plate development in rhombomere 1. We suggest a molecular explanation for this phenomenon by providing evidence that FGF signaling functions to inhibit the BMP signaling that promotes roof plate development.
This article has been cited by other articles:

|
 |

|
 |
 
M. Lagha, T. Sato, L. Bajard, P. Daubas, M. Esner, D. Montarras, F. Relaix, and M. Buckingham
Regulation of Skeletal Muscle Stem Cell Behavior by Pax3 and Pax7
Cold Spring Harb Symp Quant Biol,
November 6, 2008;
(2008)
sqb.2008.73.006v1.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Park, Y. Watanabe, G. Smyth, S. Miyagawa-Tomita, E. Meyers, J. Klingensmith, T. Camenisch, M. Buckingham, and A. M. Moon
An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart
Development,
November 1, 2008;
135(21):
3599 - 3610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Aranda, M. Alvarez, S. Turro, A. Laguna, and S. de la Luna
Sprouty2-Mediated Inhibition of Fibroblast Growth Factor Signaling Is Modulated by the Protein Kinase DYRK1A
Mol. Cell. Biol.,
October 1, 2008;
28(19):
5899 - 5911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lagha, J. D. Kormish, D. Rocancourt, M. Manceau, J. A. Epstein, K. S. Zaret, F. Relaix, and M. E. Buckingham
Pax3 regulation of FGF signaling affects the progression of embryonic progenitor cells into the myogenic program
Genes & Dev.,
July 1, 2008;
22(13):
1828 - 1837.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2008